Similar articles

• Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection.

  Proctor RA. Proctor RA. Clin Infect Dis. 2008 Feb 15;46(4):584-93. doi: 10.1086/525536. Clin Infect Dis. 2008. PMID: 18197761 Review.
• Methicillin-resistant Staphylococcus aureus: a community concern.

  Hedge DD. Hedge DD. S D Med. 2006 Oct;59(10):433, 435. S D Med. 2006. PMID: 17124921 No abstract available.
• Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.

  Grim SA, Rapp RP, Martin CA, Evans ME. Grim SA, et al. Pharmacotherapy. 2005 Feb;25(2):253-64. doi: 10.1592/phco.25.2.253.56956. Pharmacotherapy. 2005. PMID: 15767239 Review.
• Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.

  Adra M, Lawrence KR. Adra M, et al. Ann Pharmacother. 2004 Feb;38(2):338-41. doi: 10.1345/aph.1D156. Epub 2003 Dec 30. Ann Pharmacother. 2004. PMID: 14742775 Review.
• Comment on: Bactericidal activity of orally available agents against methicillin-resistant Staphylococcus aureus.

  Hmouda H, Ben Salem C, Bouraoui K, Jemni L. Hmouda H, et al. J Antimicrob Chemother. 2006 Dec;58(6):1307; author reply 1307-8. doi: 10.1093/jac/dkl417. Epub 2006 Oct 20. J Antimicrob Chemother. 2006. PMID: 17056611 No abstract available.